Lung cancer stands as the foremost health issue and the principal reason for mortality
worldwide. It is projected that India will see over 1.73 million new cases and more than …

Although various treatments are currently being developed, lung cancer still has a very high
mortality rate. Moreover, while various strategies for the diagnosis and treatment of lung …

The most recent WHO statistics of the year 2020 shows that lung cancer accounts for the
maximum cancer mortality cases, with 1.8 million deaths annually. The current treatment …

Non-small-cell lung cancer (NSCLC) afflicts about 2 million people worldwide, with both
genetic (familial) and environmental factors contributing to its development and spread. The …

Cancer is a life-threatening disease that is associated with persistent tissue injury and
uncontrolled cell growth. The treatments available to treat cancer are chemotherapy, surgery …

According to the list published by the WHO for global top ten causes of death, lung diseases
contribute nearly one-third of the total mortality. The current treatment on lung diseases …

The efficacy of current standard chemotherapy is suboptimal due to the poor solubility and
short half-lives of chemotherapeutic agents, as well as their high toxicity and lack of …

Nanostructured Lipid Carriers (NLCs) are considered second-generation lipid-based
pharmaceutical formulations in drug delivery systems. It is a more efficient drug delivery …

Cancer is one of the leading causes of mortality worldwide. Although chemotherapeutic
agents have been effectively designed to increase the survival rates of some patients, the …

Background: Around 40% of newly discovered chemical entities in pharmaceutical
industries have poor water solubility and hence they suffer from low oral bioavailability …